DOCSLIB.ORG

Supplementary Table 3. Genes Differentially Expressed (Log FC

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 3. Genes Differentially Expressed (Log FC Supplementary table 3. Genes differentially expressed (log FC > 0.45 or logFC < ‐0.45) in response to stimuli at UVJ (control versus mated). “U” represents unique to the UVJ. A. UP‐REGULATED GENES SL Gene symbol or ID U Gene ID Panther Family/subfamily Functions (Panther Classification logFC System) 1 ENSGALG00000023898 U ENSGALG00000023898/F1NWQ8 RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 9 Cellular defense response, immune 1.68 (PTHR22826:SF107) response 2 PAPPA ENSGALG00000007079/F1N850 PAPPALYSIN‐1 (PTHR19325:SF347) Immune response, response to 1.45 external stimulus 3 ENSGALG00000012602 U ENSGALG00000012602/F1NYJ8 BPI FOLD‐CONTAINING FAMILY C PROTEIN (PTHR10504:SF17) Defense response to bacterium, 1.13 response to stress 4 ITGB4 U ENSGALG00000002389/E1C9G7 INTEGRIN BETA‐4 (PTHR10082:SF6) Response to external stimulus 0.72 5 MK06_CHICK U ENSGALG00000004690/Q5F3W3 MITOGEN‐ACTIVATED PROTEIN KINASE 6 (PTHR24055:SF171) Response to stress 0.60 6 RASA4 U ENSGALG00000001876/F1NF56 RAS GTPASE‐ACTIVATING PROTEIN 4‐RELATED (PTHR10194:SF4) 0.59 7 CREB1 U ENSGALG00000008494/E1BSK3 CYCLIC AMP‐RESPONSIVE ELEMENT‐BINDING PROTEIN 1 Response to stress 0.50 (PTHR22952:SF104) 8 SPDEF U ENSGALG00000002792/F1N9W6 SAM POINTED DOMAIN‐CONTAINING ETS TRANSCRIPTION FACTOR Cellular defense response 1.98 (PTHR11849:SF182) 9 EDIL3 ENSGALG00000015630/F1NCN3 EGF‐LIKE REPEAT AND DISCOIDIN I‐LIKE DOMAIN‐CONTAINING Response to external stimulus 1.81 PROTEIN 3 (PTHR10127:SF29) 10 SRPK1 U ENSGALG00000000890/E1C5I9 SRSF PROTEIN KINASE 1 (PTHR24055:SF101) Response to stress 1.43 11 SPATA13 U ENSGALG00000017116/F1P176 SPERMATOGENESIS‐ASSOCIATED PROTEIN 13 (PTHR22826:SF103) Cellular defense response, immune 1.28 response 12 GNA14 ENSGALG00000015176/F1NU41 GUANINE NUCLEOTIDE‐BINDING PROTEIN SUBUNIT ALPHA‐14 1.05 (PTHR10218:SF57) 13 ENSGALG00000003676 U ENSGALG00000003676/E1C2U5 JUNCTION PLAKOGLOBIN (PTHR23315:SF12) 0.86 14 WNT5B ENSGALG00000012998/F1NMK6 PROTEIN WNT‐5B (PTHR12027:SF87) 0.78 15 CD99L2 U ENSGALG00000009075/F1NGN9 CD99 ANTIGEN‐LIKE PROTEIN 2 (PTHR15076:SF13) Cellular defense response 0.71 16 TSPAN1 U ENSGALG00000010343/F1NBL2 TETRASPANIN‐1 (PTHR19282:SF153) Response to external stimulus 0.69 17 PP2AA_CHICK U ENSGALG00000010273/P48463 SERINE/THREONINE‐PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT Response to stress 0.62 BETA ISOFORM (PTHR11668:SF21) 18 C1QTNF3 ENSGALG00000003338/E1C6T7 COMPLEMENT C1Q TUMOR NECROSIS FACTOR‐RELATED PROTEIN 3 Immune response 2.60 (PTHR24022:SF76) 19 KALRN ENSGALG00000011744/F1NPK0 KALIRIN (PTHR22826:SF49) Cellular defense response, immune 1.59 response 20 IL5RA U ENSGALG00000008267/E1C261 INTERLEUKIN‐5 RECEPTOR SUBUNIT ALPHA (PTHR23036:SF17) Immune response 1.36 21 DNAJB5 ENSGALG00000001918/E1BWR7 DNAJ HOMOLOG SUBFAMILY B MEMBER 5 (PTHR24077:SF227) Response to stress 1.17 22 MAPK1 U ENSGALG00000001501/F1P066 MITOGEN‐ACTIVATED PROTEIN KINASE 1 (PTHR24055:SF161) Response to stress 1.11 23 PLEKHG1 U ENSGALG00000012395/E1C0X3 SUBFAMILY NOT NAMED (PTHR22826:SF50) Cellular defense response 1.08 24 LRP11 U ENSGALG00000019987/E1C5C3 LOW‐DENSITY LIPOPROTEIN RECEPTOR‐RELATED PROTEIN 11 Response to external stimulus 0.94 (PTHR10083:SF197) 25 TNKS2 U ENSGALG00000014614/F1P4A9 TANKYRASE‐2 (PTHR24180:SF11) Response to stress 0.82 26 LOXL2 ENSGALG00000000402/E1C3U7 LYSYL OXIDASE HOMOLOG 2 (PTHR19331:SF10) Cellular defense response 0.77 27 EPHX2 U ENSGALG00000016567/F1NHP2 BIFUNCTIONAL EPOXIDE HYDROLASE 2 (PTHR10992:SF758) Response to toxic substance 0.63 28 KLF10 U ENSGALG00000016063/F1P0C2 KRUEPPEL‐LIKE FACTOR 10 (PTHR23223:SF21) Immune response 0.63 29 FZD7 U ENSGALG00000023536/F1N965 FRIZZLED‐7 (PTHR11309:SF31) 0.57 30 BRAF U ENSGALG00000012865/F1P1L9 SERINE/THREONINE‐PROTEIN KINASE B‐RAF (PTHR23257:SF360) Response to stress 0.53 31 ENSGALG00000014252 ENSGALG00000014252/F1NEQ4 SUBFAMILY NOT NAMED (PTHR11412:SF73) Immune response 3.17 32 LOC771972 ENSGALG00000020972/F1NPR2 WAP FOUR‐DISULFIDE CORE DOMAIN PROTEIN 8 (PTHR10083:SF169) Response to external stimulus 2.49 33 PTX3 U ENSGALG00000009694/F1NYP7 PENTRAXIN‐RELATED PROTEIN PTX3 (PTHR19277:SF28) Immune response, response to stress 2.12 34 SIK1 ENSGALG00000016200/F1NL00 SERINE/THREONINE‐PROTEIN KINASE SIK1 (PTHR24343:SF0) Response to stress 1.79 35 KIAA0247 U ENSGALG00000009428/E1BXY7 PROTEIN 4933426M11RIK (PTHR19325:SF6) Immune response, response to 1.76 external stimulus 36 LOC395991 ENSGALG00000006944/F1NHI6 SUBFAMILY NOT NAMED (PTHR11309:SF12) 1.48 37 PROKR2 ENSGALG00000008741/F1NNL2 PROKINETICIN RECEPTOR 2 (PTHR24242:SF189) Response to stress 1.47 38 ICK U ENSGALG00000016321/E1BTD4 SERINE/THREONINE‐PROTEIN KINASE ICK (PTHR24055:SF150) Response to stress 1.33 39 GPR133 ENSGALG00000002557/E1C2Q6 G‐PROTEIN COUPLED RECEPTOR 133‐RELATED (PTHR12011:SF216) Immune response, response to stress 1.25 40 ETS2 U ENSGALG00000016059/F1P0R7 PROTEIN C‐ETS‐2 (PTHR11849:SF167) Cellular defense response, immune 1.26 response 41 IL13RA2 ENSGALG00000020316/F1NPT6 INTERLEUKIN‐13 RECEPTOR SUBUNIT ALPHA‐2 (PTHR23036:SF89) Immune response 1.04 42 GPR37L1 U ENSGALG00000000607/F1NJ18 ENDOTHELIN B RECEPTOR‐LIKE PROTEIN 2 (PTHR24243:SF33) Response to stress 1.00 43 LPHN2 U ENSGALG00000008871/F1NN37 LATROPHILIN‐2 (PTHR12011:SF61) Immune response, response to stress 0.90 44 PDGFC_CHICK U ENSGALG00000009378/Q9I946 PLATELET‐DERIVED GROWTH FACTOR C (PTHR10127:SF570) Response to external stimulus 0.84 45 EMID2 U ENSGALG00000001752/F1NI34 SUBFAMILY NOT NAMED (PTHR24023:SF402) 0.81 46 MKNK1 ENSGALG00000010440/F1N9J6 MAP KINASE‐INTERACTING SERINE/THREONINE‐PROTEIN KINASE 1 Response to stress 0.80 (PTHR24349:SF101) 47 TSPAN9 U ENSGALG00000014346/E1BT51 TETRASPANIN‐9 (PTHR19282:SF41) Response to external stimulus 0.76 48 SUSD4 U ENSGALG00000009388/F1P041 SUSHI DOMAIN‐CONTAINING PROTEIN 4 (PTHR19325:SF207) Immune response, response to 0.73 external stimulus 49 MOCOS ENSGALG00000013149/F1NQ69 MOLYBDENUM COFACTOR SULFURASE (PTHR14237:SF19) Response to stress 0.69 50 NFATC3 U ENSGALG00000003396/F1NSQ9 NUCLEAR FACTOR OF ACTIVATED T‐CELLS, CYTOPLASMIC 3 Cellular defense response 0.61 (PTHR12533:SF6) 51 GNAT3 ENSGALG00000008427/F1P3R0 GUANINE NUCLEOTIDE‐BINDING PROTEIN G(T) SUBUNIT ALPHA‐3 0.58 (PTHR10218:SF66) 52 COL4A1 ENSGALG00000016841/F1P2R3 COLLAGEN ALPHA‐5(IV) CHAIN (PTHR24023:SF381) 0.57 53 LOC427844 U ENSGALG00000007161/E1C5R5 LEUCINE‐RICH REPEAT SERINE/THREONINE‐PROTEIN KINASE 2 Response to stress 0.52 (PTHR23257:SF417) 54 F2 ENSGALG00000008332/F1NXV6 SUBFAMILY NOT NAMED (PTHR24265:SF82) Response to external stimulus 0.48 55 GSTT1 U ENSGALG00000005204/E1BUB6 GLUTATHIONE S‐TRANSFERASE THETA 3 (PTHR11260:SF177) Response to toxic substance 1.91 56 IL12B ENSGALG00000001409/F1NNW6 INTERLEUKIN‐12 SUBUNIT BETA (PTHR11321:SF0) Cellular defense response, immune 1.73 response 57 TMPRSS2 U ENSGALG00000016144/F1NY88 TRANSMEMBRANE PROTEASE SERINE 2 (PTHR24256:SF94) Response to external stimulus 1.59 58 CNTNAP5 ENSGALG00000011577/F1NW79 CONTACTIN‐ASSOCIATED PROTEIN‐LIKE 5 (PTHR10127:SF605) Response to external stimulus 1.50 59 DNAJB11 ENSGALG00000006564/F1NVY5 DNAJ HOMOLOG SUBFAMILY B MEMBER 11 (PTHR24077:SF210) Response to stress 1.28 60 FRZB ENSGALG00000002763/F1NFU0 SECRETED FRIZZLED‐RELATED PROTEIN 3 (PTHR11309:SF76) 1.06 61 XG U ENSGALG00000016656/E1BYL8 GLYCOPROTEIN XG (PTHR15076:SF4) Cellular defense response 0.95 62 DAB2IP U ENSGALG00000001419/E1BWM9 DISABLED HOMOLOG 2‐INTERACTING PROTEIN (PTHR10194:SF26) 0.92 63 ENSGALG00000023111 U ENSGALG00000023111/E1C2X7 BPI FOLD‐CONTAINING FAMILY C PROTEIN (PTHR10504:SF17) Defense response to bacterium, 0.86 response to stress 64 COL4A5 ENSGALG00000008141/F1NDF5 COLLAGEN ALPHA‐5(IV) CHAIN (PTHR24023:SF381) 0.85 65 TSPAN6 ENSGALG00000006808/E1C857 TETRASPANIN‐6 (PTHR19282:SF169) Response to external stimulus 0.79 66 OSMR ENSGALG00000003747/F1NN77 ONCOSTATIN‐M‐SPECIFIC RECEPTOR SUBUNIT BETA Immune response 0.75 (PTHR23036:SF80) 67 LMO2 U ENSGALG00000000351/F1NU72 RHOMBOTIN‐2 (PTHR24208:SF101) Cellular defense response 0.70 68 COL4A2 ENSGALG00000016843/F1P2Q3 SUBFAMILY NOT NAMED (PTHR24023:SF354) 0.59 69 TXN U ENSGALG00000015704/P08629 THIOREDOXIN (PTHR10438:SF126) Response to stress 0.56 70 CD40 U ENSGALG00000007015/E1C9I3 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5 Cellular defense response, immune 0.54 (PTHR23097:SF103) response 71 CD276 ENSGALG00000001729/F1NZF8 CD276 ANTIGEN (PTHR24100:SF2) Cellular defense response 0.48 72 NOS1 ENSGALG00000008177/E1C799 NITRIC OXIDE SYNTHASE, BRAIN (PTHR19384:SF63) 1.68 73 NPTXR U ENSGALG00000012183/E1BUW1 NEURONAL PENTRAXIN RECEPTOR (PTHR19277:SF94) Immune response, response to stress 1.43 74 ICOSLG U ENSGALG00000016212/F1NKD4 ICOS LIGAND (PTHR24100:SF55) Cellular defense response 1.13 75 MCF2L ENSGALG00000016834/E1BT68 GUANINE NUCLEOTIDE EXCHANGE FACTOR DBS (PTHR22826:SF115) Cellular defense response, immune 0.94 response 76 VEGFA ENSGALG00000010290/F1NAQ1 VASCULAR ENDOTHELIAL GROWTH FACTOR A (PTHR12025:SF5) Response to stress 0.88 77 SIK2 U ENSGALG00000000312/E1C5R4 SERINE/THREONINE‐PROTEIN KINASE SIK2 (PTHR24343:SF145) Response to stress 0.62 78 LOC428144 U ENSGALG00000004337/E1BWZ8 SUBFAMILY NOT NAMED (PTHR24243:SF119) Response to stress 0.56 79 Q5ZJ46_CHICK U ENSGALG00000015763/Q5ZJ46 GA‐BINDING PROTEIN ALPHA CHAIN (PTHR11849:SF28) Cellular defense response 0.49 80 NCK2 U ENSGALG00000016799/F1P4Q4 CYTOPLASMIC PROTEIN NCK2 (PTHR22820:SF29) Cellular defense response 0.45 81 COCH_CHICK ENSGALG00000009920/O42163 COCHLIN (PTHR22992:SF84) Response to external stimulus 3.36 82 F13A1 ENSGALG00000012802/F1NTJ0 COAGULATION FACTOR XIII A CHAIN
Load more

Recommended publications
  • Supplemental Materials Figure 1. 80 Genes Most Highly Differentially Expressed Comparing Dedifferentiated to Well- Differentiated Liposarcoma
    Supplemental Materials Figure 1. 80 genes most highly differentially expressed comparing dedifferentiated to well- differentiated liposarcoma Figure 2. Validation of microa CDC2, RACGAP1, FGFR-2, MAD2 and CITED1 200 CDK4 by Liposarcoma Subtype 16 0 12 0 80 Expression40 Level 0 Nl Fat rray data by quantitative RT-P Well Diff 16 0 p16 by Liposarcoma Subtype Dediff 12 0 80 Myxoid Expression40 Level Round Cell 0 12 0 MDM2 by Liposarcoma Subtype 10 0 Pleomorphic Nl Fat 80 60 40 Expression Level 20 RACGAP1 by LiposarcomaWell Diff Subtype 0 70 CR for genes CDK4, MDM2, p16, 60 Dediff 50 Nl Fat 40 30 Myxoid Expression20 Level Well Diff 10 50 0 Round Cell CDC2 by Liposarcoma Subtype Dediff 40 Nl Fat Pleomorphic 30 Myxoid 20 Expression Level Well Diff 10 MAD2L1 by Liposarcoma Subtype Round Cell 60 0 50 Dediff Pleomorphic 40 Nl Fat 30 Myxoid 20 Expression Level Well Diff 10 FGFR-2 by Liposarcoma Subtype 0 Round Cell 200 16 0 Dediff Nl Fat Pleomorphic 12 0 Myxoid 80 Expression Level Well Diff 40 Round Cell 0 Dediff Pleomorphic Nl Fat Myxoid Well Diff CITED1 by Liposarcoma Subtype Round Cell 10 0 80 Dediff Pleomorphic 60 40 Myxoid Expression Level 20 0 Round Cell Nl Fat Pleomorphic Well Diff Dediff Myxoid Round Cell Pleomorphic Table 1. 142 Gene classifier for liposarcoma subtype The genes used for each pair wise subtype comparison are grouped together. The flag column indicates which genes are unique to each subtype comparison. The values show the mean expression levels (actually the mean of the log expression levels was computed and than transformed back to absolute expression level).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid
    The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome Annette K. Brenner, Elise Aasebø, Maria Hernandez-Valladares, Frode Selheim, Frode Berven, Ida-Sofie Grønningsæter, Sushma Bartaula-Brevik and Øystein Bruserud Supplementary Material S2 of S31 Table S1. Detailed information about the 68 AML patients included in the study. # of blasts Viability Proliferation Cytokine Viable cells Change in ID Gender Age Etiology FAB Cytogenetics Mutations CD34 Colonies (109/L) (%) 48 h (cpm) secretion (106) 5 weeks phenotype 1 M 42 de novo 241 M2 normal Flt3 pos 31.0 3848 low 0.24 7 yes 2 M 82 MF 12.4 M2 t(9;22) wt pos 81.6 74,686 low 1.43 969 yes 3 F 49 CML/relapse 149 M2 complex n.d. pos 26.2 3472 low 0.08 n.d. no 4 M 33 de novo 62.0 M2 normal wt pos 67.5 6206 low 0.08 6.5 no 5 M 71 relapse 91.0 M4 normal NPM1 pos 63.5 21,331 low 0.17 n.d. yes 6 M 83 de novo 109 M1 n.d. wt pos 19.1 8764 low 1.65 693 no 7 F 77 MDS 26.4 M1 normal wt pos 89.4 53,799 high 3.43 2746 no 8 M 46 de novo 26.9 M1 normal NPM1 n.d. n.d. 3472 low 1.56 n.d. no 9 M 68 MF 50.8 M4 normal D835 pos 69.4 1640 low 0.08 n.d.
    [Show full text]
  • Regulation Of
    Sede Amministrativa: Università degli Studi di Padova Dipartimento di Istologia, Microbiologia e Biotecnologie Mediche SCUOLA DI DOTTORATO DI RICERCA IN BIOSCIENZE INDIRIZZO GENETICA CICLO XXIII EXPRESSION AND FUNCTIONAL ROLE OF EMILIN-3, A PECULIAR MEMBER OF THE EMILIN/MULTIMERIN FAMILY Direttore della Scuola : Ch.mo Prof. Giuseppe Zanotti Coordinatore d’indirizzo: Ch.mo Prof. Paolo Bonaldo Supervisore :Ch.mo Prof. Paolo Bonaldo Dottorando : Alvise Schiavinato 1 2 THESIS CONTENTS ABSTRACT ________________________________________________________________________________________ 5 ABSTRACT (ITALIANO)__________________________________________________________________________ 6 INTRODUCTION__________________________________________________________________________________ 7 THE EXTRACELLULAR MATRIX_____________________________________________________________________ 7 REGULATION OF TGF−Β SIGNALING BY THE EXTRACELLULAR MATRIX______________________________ 9 EMILIN-1________________________________________________________________________________________11 THE EMILIN/MULTIMERIN FAMILY ______________________________________________________________12 THE EMILIN/MULTIMERIN FAMILY IN ZEBRAFISH ________________________________________________13 STRUCTURE AND FUNCTION OF THE NOTOCHORD _________________________________________________14 AIM OF THE RESEARCH ______________________________________________________________________16 MATERIALS AND METHODS__________________________________________________________________ 17 ANIMALS ________________________________________________________________________________________17
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • G Protein-Coupled Receptors
    G PROTEIN-COUPLED RECEPTORS Overview:- The completion of the Human Genome Project allowed the identification of a large family of proteins with a common motif of seven groups of 20-24 hydrophobic amino acids arranged as α-helices. Approximately 800 of these seven transmembrane (7TM) receptors have been identified of which over 300 are non-olfactory receptors (see Frederikson et al., 2003; Lagerstrom and Schioth, 2008). Subdivision on the basis of sequence homology allows the definition of rhodopsin, secretin, adhesion, glutamate and Frizzled receptor families. NC-IUPHAR recognizes Classes A, B, and C, which equate to the rhodopsin, secretin, and glutamate receptor families. The nomenclature of 7TM receptors is commonly used interchangeably with G protein-coupled receptors (GPCR), although the former nomenclature recognises signalling of 7TM receptors through pathways not involving G proteins. For example, adiponectin and membrane progestin receptors have some sequence homology to 7TM receptors but signal independently of G-proteins and appear to reside in membranes in an inverted fashion compared to conventional GPCR. Additionally, the NPR-C natriuretic peptide receptor has a single transmembrane domain structure, but appears to couple to G proteins to generate cellular responses. The 300+ non-olfactory GPCR are the targets for the majority of drugs in clinical usage (Overington et al., 2006), although only a minority of these receptors are exploited therapeutically. Signalling through GPCR is enacted by the activation of heterotrimeric GTP-binding proteins (G proteins), made up of α, β and γ subunits, where the α and βγ subunits are responsible for signalling. The α subunit (tabulated below) allows definition of one series of signalling cascades and allows grouping of GPCRs to suggest common cellular, tissue and behavioural responses.
    [Show full text]
  • Multi-Functionality of Proteins Involved in GPCR and G Protein Signaling: Making Sense of Structure–Function Continuum with In
    Cellular and Molecular Life Sciences (2019) 76:4461–4492 https://doi.org/10.1007/s00018-019-03276-1 Cellular andMolecular Life Sciences REVIEW Multi‑functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder‑based proteoforms Alexander V. Fonin1 · April L. Darling2 · Irina M. Kuznetsova1 · Konstantin K. Turoverov1,3 · Vladimir N. Uversky2,4 Received: 5 August 2019 / Revised: 5 August 2019 / Accepted: 12 August 2019 / Published online: 19 August 2019 © Springer Nature Switzerland AG 2019 Abstract GPCR–G protein signaling system recognizes a multitude of extracellular ligands and triggers a variety of intracellular signal- ing cascades in response. In humans, this system includes more than 800 various GPCRs and a large set of heterotrimeric G proteins. Complexity of this system goes far beyond a multitude of pair-wise ligand–GPCR and GPCR–G protein interactions. In fact, one GPCR can recognize more than one extracellular signal and interact with more than one G protein. Furthermore, one ligand can activate more than one GPCR, and multiple GPCRs can couple to the same G protein. This defnes an intricate multifunctionality of this important signaling system. Here, we show that the multifunctionality of GPCR–G protein system represents an illustrative example of the protein structure–function continuum, where structures of the involved proteins represent a complex mosaic of diferently folded regions (foldons, non-foldons, unfoldons, semi-foldons, and inducible foldons). The functionality of resulting highly dynamic conformational ensembles is fne-tuned by various post-translational modifcations and alternative splicing, and such ensembles can undergo dramatic changes at interaction with their specifc partners.
    [Show full text]
  • Downloaded 18 July 2014 with a 1% False Discovery Rate (FDR)
    UC Berkeley UC Berkeley Electronic Theses and Dissertations Title Chemical glycoproteomics for identification and discovery of glycoprotein alterations in human cancer Permalink https://escholarship.org/uc/item/0t47b9ws Author Spiciarich, David Publication Date 2017 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California Chemical glycoproteomics for identification and discovery of glycoprotein alterations in human cancer by David Spiciarich A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Chemistry in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Carolyn R. Bertozzi, Co-Chair Professor David E. Wemmer, Co-Chair Professor Matthew B. Francis Professor Amy E. Herr Fall 2017 Chemical glycoproteomics for identification and discovery of glycoprotein alterations in human cancer © 2017 by David Spiciarich Abstract Chemical glycoproteomics for identification and discovery of glycoprotein alterations in human cancer by David Spiciarich Doctor of Philosophy in Chemistry University of California, Berkeley Professor Carolyn R. Bertozzi, Co-Chair Professor David E. Wemmer, Co-Chair Changes in glycosylation have long been appreciated to be part of the cancer phenotype; sialylated glycans are found at elevated levels on many types of cancer and have been implicated in disease progression. However, the specific glycoproteins that contribute to cell surface sialylation are not well characterized, specifically in bona fide human cancer. Metabolic and bioorthogonal labeling methods have previously enabled enrichment and identification of sialoglycoproteins from cultured cells and model organisms. The goal of this work was to develop technologies that can be used for detecting changes in glycoproteins in clinical models of human cancer.
    [Show full text]
  • Supplementary Table 2
    Supplementary Table 2. Differentially Expressed Genes following Sham treatment relative to Untreated Controls Fold Change Accession Name Symbol 3 h 12 h NM_013121 CD28 antigen Cd28 12.82 BG665360 FMS-like tyrosine kinase 1 Flt1 9.63 NM_012701 Adrenergic receptor, beta 1 Adrb1 8.24 0.46 U20796 Nuclear receptor subfamily 1, group D, member 2 Nr1d2 7.22 NM_017116 Calpain 2 Capn2 6.41 BE097282 Guanine nucleotide binding protein, alpha 12 Gna12 6.21 NM_053328 Basic helix-loop-helix domain containing, class B2 Bhlhb2 5.79 NM_053831 Guanylate cyclase 2f Gucy2f 5.71 AW251703 Tumor necrosis factor receptor superfamily, member 12a Tnfrsf12a 5.57 NM_021691 Twist homolog 2 (Drosophila) Twist2 5.42 NM_133550 Fc receptor, IgE, low affinity II, alpha polypeptide Fcer2a 4.93 NM_031120 Signal sequence receptor, gamma Ssr3 4.84 NM_053544 Secreted frizzled-related protein 4 Sfrp4 4.73 NM_053910 Pleckstrin homology, Sec7 and coiled/coil domains 1 Pscd1 4.69 BE113233 Suppressor of cytokine signaling 2 Socs2 4.68 NM_053949 Potassium voltage-gated channel, subfamily H (eag- Kcnh2 4.60 related), member 2 NM_017305 Glutamate cysteine ligase, modifier subunit Gclm 4.59 NM_017309 Protein phospatase 3, regulatory subunit B, alpha Ppp3r1 4.54 isoform,type 1 NM_012765 5-hydroxytryptamine (serotonin) receptor 2C Htr2c 4.46 NM_017218 V-erb-b2 erythroblastic leukemia viral oncogene homolog Erbb3 4.42 3 (avian) AW918369 Zinc finger protein 191 Zfp191 4.38 NM_031034 Guanine nucleotide binding protein, alpha 12 Gna12 4.38 NM_017020 Interleukin 6 receptor Il6r 4.37 AJ002942
    [Show full text]
  • Phototransduction Cascade Activation Steps
    1 ORIGINAL RESEARCH ARTICLE Evolution of the vertebrate phototransduction cascade activation steps Trevor D. Lamb1 and David M. Hunt2,3 1Eccles Institute of Neuroscience, John Curtin School of Medical Research, The Australian National University, ACT 2600, Australia, and 2The Lions Eye Institute and 3School of Biological Sciences, The University of Western Australia, WA 6009, Australia. Correspondence: Professor Trevor Lamb <[email protected]> Keywords: Evolution; Phototransduction; Transducin; Phosphodiesterase; Cyclic nucleotide- gated channel; Opsin ABSTRACT We examine the molecular phylogeny of the proteins underlying the activation steps of vertebrate phototransduction, for both agnathan and jawed vertebrate taxa. We expand the number of taxa analysed and we update the alignment and tree building methodology from a previous analysis. For each of the four primary components (the G-protein transducin alpha subunit, GαT, the cyclic GMP phosphodiesterase, PDE6, and the alpha and beta subunits of the cGMP-gated ion channel, CNGC), the phylogenies appear consistent with expansion from an ancestral proto-vertebrate cascade during two rounds of whole-genome duplication followed by divergence of the agnathan and jawed vertebrate lineages. In each case, we consider possible scenarios for the underlying gene duplications and losses, and we apply relevant constraints to the tree construction. From tests of the topology of the resulting trees, we obtain a scenario for the expansion of each component during 2R that accurately fits the observations. Similar analysis of the visual opsins indicates that the only expansion to have occurred during 2R was the formation of Rh1 and Rh2. Finally, we propose a hypothetical scenario for the conversion of an ancestral chordate cascade into the proto-vertebrate phototransduction cascade, prior to whole-genome duplication.
    [Show full text]
  • The Specificity of Downstream Signaling for A1 and A2AR
    biomedicines Article The Specificity of Downstream Signaling for A1 and A2AR Does Not Depend on the C-Terminus, Despite the Importance of This Domain in Downstream Signaling Strength Abhinav R. Jain 1 , Claire McGraw 1 and Anne S. Robinson 1,2,* 1 Department of Chemical and Biomolecular Engineering, Tulane University, New Orleans, LA 70118, USA; [email protected] (A.R.J.); [email protected] (C.M.) 2 Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA * Correspondence: [email protected]; Tel.: +1-412-268-7673 Received: 17 November 2020; Accepted: 9 December 2020; Published: 13 December 2020 Abstract: Recent efforts to determine the high-resolution crystal structures for the adenosine receptors (A1R and A2AR) have utilized modifications to the native receptors in order to facilitate receptor crystallization and structure determination. One common modification is a truncation of the unstructured C-terminus, which has been utilized for all the adenosine receptor crystal structures obtained to date. Ligand binding for this truncated receptor has been shown to be similar to full-length receptor for A2AR. However, the C-terminus has been identified as a location for protein-protein interactions that may be critical for the physiological function of these important drug targets. We show that variants with A2AR C-terminal truncations lacked cAMP-linked signaling compared to the full-length receptor constructs transfected into mammalian cells (HEK-293). In addition, we show that in a humanized yeast system, the absence of the full-length C-terminus affected downstream signaling using a yeast MAPK response-based fluorescence assay, though full-length receptors showed native-like G-protein coupling.
    [Show full text]
  • Analysis of the Potential Correlation Between Gastric Cancer and Gastrointestinal Microbiota Via In-Silico Data Mining
    Analysis of the potential correlation between gastric cancer and gastrointestinal microbiota via in-silico data mining Xuelu Ding Tianjin Medical University Yukun Zhu Tianjin Medical University Zhaoyuan She Tianjin Medical University Xuewen Liu Tianjin Medical University Cancan Zhang Tianjin First Central Hospital Xuying Ma Tianjin Medical University Feng Wang Tianjin Medical University Fei Wang Tianjin Medical University General Hospital Xin Geng ( [email protected] ) https://orcid.org/0000-0003-0604-5392 Research Keywords: bioinformatics, microbiota, gastric cancer, databases Posted Date: December 18th, 2019 DOI: https://doi.org/10.21203/rs.2.19110/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/17 Abstract Background Emerging evidence shows the gastrointestinal microbiome might play an important role in the carcinogenesis of gastric cancer. While Helicobactor pylori has been reported to be a specic risk factor of gastric cancer, it is still controversial whether signicant difference of non- H. pylori microbiota exists between gastric cancer patients and healthy control. Results In this study, we employed multiple bioinformatic databases to excavate the potential correlation between gastrointestinal microbiome and gastric cancer. The databases involved in this investigation include HMDB, STITCH, OMIM, GWAS Catalog, WebGestalt, Toppgene, GeneMANIA. In addition, the network diagrams were built by use of Cytoscape software. Notably, our results showed that 33 common genes participate in both gastrointestinal microbiome and gastric cancer. The further analysis of these common genes suggested that there was a wide array of interactions and pathways in which the correlation between gastrointestinal microbiome and gastric cancer is involved.
    [Show full text]